<DOC>
	<DOCNO>NCT01491009</DOCNO>
	<brief_summary>The aim study compare effect remifentanil-dexmedetomidine remifentanil-midazolam mini-mental state examination ( MMSE ) monitor anesthesia care ( MAC ) patient undergo cystoscopy .</brief_summary>
	<brief_title>Comparison Remifentanil With Dexmedetomidine Midazolam Regards Sedation Effectivity Postoperative Cognitive Functions Cystoscopies</brief_title>
	<detailed_description>Forty patient undergoing cystoscopy receive remifentanil infusion 0.05 microgram per kg-1 min-1 randomize two group : Either dexmedetomidine 1 microgram per kg -1 ( GroupD ) midazolam 0.2 mg kg-1h-1 ( GroupM ) administer intravenously first 10 minute . Subsequently anesthesia maintain use bispectral index ( BIS ) continuous infusion dexmedetomidine 0.2-0.7 microgram per kg-1h-1 midazolam 0.05-0.15 mgkg-1h-1 . Heart rate , mean arterial pressure , MMSE , sedation patient 's surgeon 's satisfaction determine .</detailed_description>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>patient indication cystoscopy must able sedation hypersensitivity drug use morbid obesity coronary disease diabetes mellitus endocrinologic disease pregnancy psychomotor disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Dexmedetomidine</keyword>
	<keyword>midazolam</keyword>
	<keyword>remifentanil</keyword>
	<keyword>mini-mental state examination</keyword>
	<keyword>monitor anaesthesia care</keyword>
	<keyword>cystoscopy</keyword>
	<keyword>sedation</keyword>
</DOC>